“Taking possibility back” across oncology’s toughest frontiers

STAT Brand Studio
09/10/2025 6 min
“Taking possibility back” across oncology’s toughest frontiers

Listen "“Taking possibility back” across oncology’s toughest frontiers"

Descargar episodio

Episode Synopsis

What does it take to transform the outlook for patients facing some of the most difficult cancers? Dr. Dietmar Berger, Chief Medical Officer at Gilead
Sciences, shares how the company is tackling urgent needs in triple negative breast cancer (TNBC) and pioneering the next generation of CAR-T therapies to reshape what’s possible in oncology.



: https://www.statnews.com/sponsor/2025/10/09/taking-possibility-back-across-oncologys-toughest-frontiers/



Photo: Radhika Patnala/Endosymbiont GmBH

More episodes of the podcast STAT Brand Studio

Can provider education and smarter policy close the biosimilars gap? 18/09/2025
From research to advocacy: A new fellowship honors Stephen Harrison’s vision in MASH research 25/08/2025
Supporting science from bench to bioproduction 12/06/2025
Building the future of life sciences in NYC 22/05/2025
Puerto Rico’s competitive edge: Workforce, incentives, and cutting-edge infrastructure 20/03/2025
Fighting colorectal cancer disparities with real-world data 02/01/2025
Three-year degree expands access to medical education and fast-tracks specialty study 04/12/2024
Top-ranked health system launches wide-ranging molecular oncology program 06/11/2024
Approaching patient care with understanding, respect, and humility 09/10/2024
STAT Summit 2024 07/08/2024
© 2003-2025 ZARZA | AHEAD OF OUR TIME
privacy policy
In God we trust In God we trust
PreSales Questions? Click Here
or call our toll-free line at +1-888-5002068 Miami, Florida, USA